Anaplastic large cell lymphoma (ALCL), ALK-positive, is a type of non-Hodgkin lymphoma characterized by the presence of anaplastic large cells. This condition primarily affects lymph nodes in the inguinal region and low lymphatic areas. Accurate coding with ICD-10 Code C84.65 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this malignancy.
ICD-10 Code C84.65 represents anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK) positive, specifically affecting the lymph nodes in the inguinal region and low lymphatic areas. This code is used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, facilitating accurate treatment planning and reimbursement processes.
Anaplastic large cell lymphoma (ALCL), ALK-positive, is a rare and aggressive form of non-Hodgkin lymphoma that typically presents in lymph nodes, particularly in the inguinal region. The condition is driven by genetic mutations that lead to uncontrolled cell proliferation, necessitating prompt medical intervention. Early diagnosis and treatment are critical to improving patient outcomes.
In SOAP notes, ICD-10 Code C84.65 is utilized to document the diagnosis of anaplastic large cell lymphoma, ALK-positive. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
ICD-10 Code C84.65 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.
The management of anaplastic large cell lymphoma, ALK-positive, often requires hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.65 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with automated differential white blood cell count. |
Common Questions About Using ICD-10 Code C84.65 for Anaplstc lg cell lymph, ALK-pos, nodes of ing rgn & low lmb
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience pain in affected areas.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of lymph nodes to confirm the presence of anaplastic large cells.
What is the treatment for Anaplastic large cell lymphoma?
Treatment often includes chemotherapy, targeted therapy, and sometimes radiation. The specific regimen depends on the patient's overall health and disease stage.
Is Anaplastic large cell lymphoma curable?
While Anaplastic large cell lymphoma can be aggressive, many patients respond well to treatment, and some may achieve remission. Early diagnosis and intervention are crucial.
Clinical Notes
SOAP notes
DAP notes
AI medical notes